NRSN (NRSN) Stock Price & Analysis
NRSN (NRSN) fell 1.59% to USD 0.5 as of September 8, 2026 at 15:33 UTC, according to Nexqual real-time market data.
NRSN last closed at USD 0.5; the session ranged USD 0.46–0.52 on volume of 367,857 shares. Market capitalization is —, with a 52-week range of USD 0.25–1.98 (NCM). Source: Nexqual, September 8, 2026 at 15:33 UTC.
Key Statistics (as of September 8, 2026 at 15:33 UTC)
| Price | USD 0.5 |
|---|---|
| Change | ▼ 1.59% (down) |
| Previous Close | USD 0.5 |
| Open | USD 0.5 |
| Day Range | USD 0.46 – 0.52 |
| 52-Week Range | USD 0.25 – 1.98 |
| Volume | 367,857 shares |
| Market Cap | — |
| Exchange | NCM |
Technical Analysis (NRSN)
Nexqual's technical model rates NRSN "SELL" based on 2 bullish and 4 bearish signals across 127 daily candles, as of September 8, 2026 at 15:33 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 53.8 (neutral) |
| vs SMA50 | Below (USD 0.55) |
| MACD | -0.02 (negative) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| REVB | Revelation Biosciences, Inc. | USD 1 | ▼ 0.99% |
| IMMX | Immix Biopharma, Inc. | USD 13.32 | ▼ 3.72% |
| BTTX | Better Therapeutics, Inc. | USD 0 | ▲ 0% |
| QNRX | Quoin Pharmaceuticals, Ltd. | USD 7.13 | ▼ 9.4% |
| KTTA | Pasithea Therapeutics Corp. | USD 0.6 | ▲ 2.76% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 15:33 UTC. This page is informational and not investment advice.